Key result
Only ~16% of AF patients admitted with cardioembolic stroke receive adequate pre-admission thromboprophylaxis.
Why the study?
The study aimed to evaluate the basic clinicopathological characteristics and pharmacological history of patients with atrial fibrillation at the time of cardioembolic stroke.
Cohort (n=99)
No
Highlights a severe gap in outpatient care where only 16.2% of high-risk atrial fibrillation patients received adequate anticoagulation prior to suffering a cardioembolic stroke.
Answers are grounded in this paper and cite their sources.
AF patients with cardioembolic stroke show distinct characteristics; leaves open whether these inform risk stratification or therapy in prospective studies.
Aim. To evaluate basic clinicopathologicalcharacteristics of patients with atrial fibrillationand pharmacological anamnesis at the time of cardioembolicstroke. Material and Methods. Study included 99 patientswith atrial fibrillation admitted to SeredavinSamara Regional Clinical Hospital due to cardioembolicstroke. The follow-up duration was 1year. Results. The average age of the patients was69.1 ± 8.7 years. Patients with atrial fibrillationand acute cardioembolic stroke were characterizedby multimorbidity. Arterial hypertension, chronickidney disease, and diabetes mellitus were diagnosedin 96/99 (97.0%), 60/99 (60.6%), and 22/99(22.2%) patients, respectively. Average risk scoreaccording to the CHA2DS2-VASc scale before admissionwas 4.51 ± 1.2 points; therefore, 96 patientshad indications for anticoagulant therapy (≥2 points on the CHA2DS2-VASc scale). However,adequate prevention of thromboembolic complicationsbefore admission was carried out only in16/99 (16.2%) patients. Conclusion. These results demonstrate a lowquality of outpatient care in patients with atrialfibrillation. Most likely, this can be explained bythe lack of awareness about the risks of potentialcomplications and low compliance.
No takes yet. Share an insight, caveat, or question.
Efimova et al. (2020) conducted a cohort in Atrial fibrillation with acute cardioembolic stroke (n=99). Pre-admission anticoagulant therapy was evaluated on Adequate pre-admission prevention of thromboembolic complications. Adequate pre-admission thromboembolic prevention was achieved in only 16.2% (16/99) of atrial fibrillation patients admitted with cardioembolic stroke, despite 97.0% having CHA2DS2-VASc ≥2.
Synapse has enriched 10 related papers. Consider them for comparative context: